Health Condition 1: null- Bronchial Asthma
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Willing to report for follow up even after most troublesome symptom(s) are gone. 2. Consider a diagnosis of asthma and perform spirometry if any of these indicators are present: a. The symptoms of dyspnoea, cough and/or wheezing, especially nocturnal, difficulty in breathing or chest tightness; b. With acute episodes: hyperinflation of thorax, decreased breath sounds, high pitched wheezing, and use of accessory muscles; c. Symptoms worse in presence of exercise, viral infections, inhaled allergens, irritants, changes in weather, strong emotional expression, stress, menstrual cycles; d. Reversible airflow obstruction: FEV1 >12% or >200 ml from baseline or increase in FEV1 >10% of predicted after inhalation of bronchodilator, if able to perform spirometry.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women 2. Other diseases causing pulmonary obstruction 3. Other associated pathologies (like heart diseases, T.B.) 4. On allopathic drugs, other than for hypertension or diabetes mellitus 5. Other ongoing treatment which is likely to interfere with the course of this treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To observe the change in spirometry measurement FEV1, in all patients more than 5 years old when asthma is stable at the end of 1 year of treatment.Timepoint: Baseline, 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To observe the change in spirometry measurements (FVC, FEV1/FVC) in all patients more than 5 years old when asthma is stable at the end of 1 year of treatment. 2. To observe the change in Asthma symptom utility index at the end of 1 year of treatment. 3. To observe the change in Quality of life (WHO-QoL) score at end of 1 year of treatment. Timepoint: Baseline, 1 year | — |
Countries
India
Contacts
Central Council for Research in Homoeopathy